000 01767 a2200517 4500
005 20250512034136.0
264 0 _c19861107
008 198611s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.30.2.310
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRusconi, F
245 0 0 _aAztreonam in the treatment of severe urinary tract infections in pediatric patients.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cAug 1986
300 _a310-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAztreonam
_xmetabolism
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCitrobacter
_xdrug effects
650 0 4 _aEnterobacter
_xdrug effects
650 0 4 _aEnterobacteriaceae Infections
_xcomplications
650 0 4 _aEscherichia coli
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aKidney Diseases
_xmetabolism
650 0 4 _aKinetics
650 0 4 _aKlebsiella pneumoniae
_xdrug effects
650 0 4 _aMale
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aProteus mirabilis
_xdrug effects
650 0 4 _aPseudomonas Infections
_xcomplications
650 0 4 _aPseudomonas aeruginosa
_xdrug effects
650 0 4 _aUrinary Tract Infections
_xcomplications
650 0 4 _aUrologic Diseases
_xcomplications
700 1 _aAssael, B M
700 1 _aBoccazzi, A
700 1 _aColombo, R
700 1 _aCrossignani, R M
700 1 _aGarlaschi, L
700 1 _aRancilio, L
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 30
_gno. 2
_gp. 310-4
856 4 0 _uhttps://doi.org/10.1128/AAC.30.2.310
_zAvailable from publisher's website
999 _c3100246
_d3100246